Rotavirus infection and the current status of rotavirus vaccines

Journal of the Formosan Medical Association

Volumn 111, Issue 4, 2012, Pages 183-193

  Chen, Shou Chien ^a,b   Tan, Lia Beng ^c   Huang, Li Min ^d   Chen, Kow Tong ^e  

^a Da Chien General Hospital   (Taiwan)

^b Ta Tung University   (Taiwan)

^c God's Help Hospital   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Epidemiology; Gastroenteritis; Rotavirus; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE;

CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIARRHEA; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG WITHDRAWAL; ECONOMIC ASPECT; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFECTION CONTROL; INTUSSUSCEPTION; NEWBORN; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); POSTMARKETING SURVEILLANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; ROTAVIRUS; ROTAVIRUS INFECTION; SEROTYPE; TREATMENT OUTCOME; VACCINATION; VIRAL GASTROENTERITIS; VIRUS STRAIN; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

GASTROENTERITIS; HUMANS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 84862817929     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.09.024     Document Type: Review

References (125)

1. Parashar U.D., Gibson C.J., Bresse J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12(2):304-306.
2. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200(1):S9-15.
3. Bilcke J., Van Damme P., Van Ranst M., Hens N., Aerts M., Beutels P. Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis. PLoS ONE 2009, 4(6):e6060.
4. Chanran A., Fitzwater S., Zhen A., Santosham M. Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics: Target Ther 2010, 4:213-229.
5. Patel M.M., Steele D., Gentsch J.R., Wecker J., Glass R.I., Parashar U.D. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011, 30:S1-S5.
6. Estes M.K., Kapikian A.Z. Rotaviruses. Fields virology 2007, 1917-1994. Lippincott, Williams and Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
7. Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973, 2(7841):1281-1283.
8. Hoshino Y., Kapikian A.Z. Rotavirus serotypes: classification and importance in epidemiology, immunity and vaccine development. J Health Popul Nutr 2000, 18(1):5-14.
9. Dennehy P.H. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008, 21(1):198-208.
10. Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Banyai K., Ramachandran M., et al. Serotypes diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005, 192:S146-S159.
11. Bernstein D.I., Ward R.L. Rotaviruses. Textbook of pediatric infectious diseases 2004, vol 2:2110-2133. Saunders, Philadelphia. 5th ed.
12. Chen S.M., Ni Y.H., Chen H.L., Chang M.H. Microbial etiology of acute gastroenteritis in hospitalized children in Taiwan. J Formos Med Assoc 2006, 105:964-970.
13. Yang S.Y., Hwang K.P., Wu F.T., Wu H.S., Hsiung C.A., Chang W.C., et al. Epidemiology and clinical peculiarities of norovirus and rotavirus infection in hospitalized young children with acute diarrhea in Taiwan, 2009. J Microbiol Immunol Infect 2010, 43(6):506-514.
14. Staat M.A., Azimi P.H., Berke T., Roberts N., Bernstein D.I., Ward R.L., et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002, 21(3):221-227.
15. Lee J.T., Lee C.N., Shao P.L., Chang L.Y., Lu C.Y., Lee P.I., et al. Clinical characteristics of nosocomial rotavirus infection in children in Taiwan. J Formos Med Assoc 2008, 107(10):791-797.
16. O'Ryan M.L., Lucero Y., Prado V., Santolaya M.E., Rabello M., Solis Y., et al. Symptomatic and asymptomatic rotavirus and norovirus infections during infancy in a Chilean birth cohort. Pediatr Infect Dis J 2009, 28(10):879-884.
17. Yang S.T., Lin L.H., Wu H.M. Clinical characteristics of rotavirus gastroenteritis in children in a medical center. Pediatr Neonatol 2010, 51(2):112-115.
18. Weng W.C., Hirose S., Lee W.T. Benign convulsions with mild gastroenteritis: is it associated with sodium channel gene SCN1A mutation?. J Child Neurol 2010, 25(12):1521-1524.
19. Hung C.W., Wu W.F., Wu C.L. Rotavirus gastroenteritis complicated with toxic megacolon. Acta Paediatr 2009, 98(11):1850-1852.
20. Wu T.C., Liu H.H., Chen Y.J., Tang R.B., Hwang B.T., Yuan H.C. Comparison of clinical features of childhood norovirus and rotavirus gastroenteritis in Taiwan. J Chin Med Assoc 2008, 71(11):566-570.
21. Liu L.J., Yang Y.J., Kuo P.H., Wang S.M., Liu C.C. Diagnostic value of bacterial stool cultures and viral antigen tests based on clinical manifestations of acute gastroenteritis in pediatric patients. Eur J Clin Microbiol Infect Dis 2005, 24(8):559-561.
22. Richardson S., Grimwood K., Gorrell R., Palombo E., Barnes G., Bishop R. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998, 351(9119):1844-1848.
23. Anderson E.J., Weber S.G. Rotavirus infections in adults. Lancet Infect Dis 2004, 4(2):91-99.
24. Sharma R., Hudak M.L., Premachandra B.R., Stevens G., Monteiro C.B., Bradshaw J.A., et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J 2002, 21(12):1099-1105.
25. Committee on Infectious Diseases, American Academy of Pediatrics Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 2009, 123(5):1412-1420.
26. Cunliffe N.A., Gondwe J.S., Kirkwood C.D., Graham S.M., Nhlane N.M., Thindwa B.D., et al. Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet 2001, 358(9281):550-555.
27. Lan W.T., Lee H.C., Yeung C.Y., Jiang C.B., Kao H.A., Hung H.Y., et al. Concomitant rotavirus and Salmonella infections in children with acute diarrhea. Pediatr Neonatol 2009, 50(1):8-12.
28. Chen S.Y., Tsai C.N., Chao H.C., Lai M.W., Lin T.Y., Ko T.Y., et al. Acute gastroenteritis caused by multiple enteric pathogens in children. Epidemiol Infect 2009, 137(7):932-935.
29. Hung T.Y., Liu M.C., Hsu C.F., Lin Y.C. Rotavirus infection increases the risk of bacteremia in children with nontyphoid Salmonella gastroenteritis. Eur J Clin Microbiol Infect Dis 2009, 28(4):425-428.
30. Ward R.L. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse method. Viral Immunol 2003, 16(1):17-24.
31. Blutt S.E., Kirkwood C.D., Parreño V., Warfield K.L., Ciarlet M., Estes M.K., et al. Rotavirus antigenaemia and viraemia: a common event?. Lancet 2003, 362(9394):1445-1449.
32. Sugata K., Taniguchi K., Yiu A., Miyake F., Suga S., Asano Y., et al. Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics 2008, 122(2):392-397.
33. Gladstone B.P., Ramani S., Mukhopadhya I., Muliyil J., Sarkar R., Rehman A.M., et al. Protection effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 2011, 365:337-346.
34. Desselberger U., Huppertz H.I. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis 2011, 203(2):188-195.
35. Ward R.L., Bernstein D.I., Young E.C., Sherwood J.R., Knowlton D.R., Schiff G.M. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis 1986, 154(5):871-880.
36. Ansari S.A., Springthorpe V.S., Sattar S.A. Survival and vehicular spread of human rotaviruses: possible relation to seasonality of outbreaks. Rev Infect Dis 1991, 13(3):448-461.
37. Barnes G.L., Callaghan S.L., Kirkwood C.D., Bogdanovic-Sakran N., Johnston L.J., Bishop R.F. Excretion of serotype G1 rotavirus strains by asymptomatic staff: a possible source of nosocomial infection. J Pediatr 2003, 142(6):722-725.
38. Ramani S., Arumugam R., Gopalarathinam N., Mohanty I., Mathew S., Gladstone B.P., et al. Investigation of the environment and of mothers in transmission of rotavirus infections in the neonatal nursery. J Med Virol 2008, 80(6):1099-1105.
39. Zerr D.M., Allpress A.L., Heath J., Bornemann R., Bennett E. Decreasing hospital-associated rotavirus infection: a multidisciplinary hand hygiene campaign in a children's hospital. Pediatr Infect Dis J 2005, 24(5):397-403.
40. Bishop R.F., Masendycz P.J., Bugg H.C., Carlin J.B., Barnes G.L. Epidemiological patterns of rotaviruses causing severe gastroenteritis in young children throughout Australia from 1993 to 1996. J Clin Microbiol 2001, 39(3):1085-1091.
41. Prince D.S., Astry C., Vonderfecht S., Jakab G., Shen F.M., Yolken R.H. Aerosol transmission of experimental rotavirus infection. Pediatr Infect Dis 1986, 5(2):218-222.
42. Dennehy P.H. Transmission of rotavirus and other enteric pathogens in the home. Pediatr Infect Dis J 2000, 19(10):S103-S105.
43. Fragoso M., Kumar A., Murray D.L. Rotavirus in nasopharyngeal secretions of children with upper respiratory tract infections. Diagn Microbiol Infect Dis 1986, 4(1):87-88.
44. Zheng B.J., Chang R.X., Ma G.Z., Xie J.M., Liu Q., Liang X.R., et al. Rotavirus infection of the oropharynx and respiratory tract in young children. J Med Virol 1991, 34(1):29-37.
45. Goldwater P., Chrystie I., Banatvala J. Rotaviruses and the respiratory tract. Br Med J 1979, 2(6204):1551.
46. Wilde J., Van R., Pickering L., Eiden J., Yolken R. Detection of rotaviruses in the day care environment by reverse transcriptase polymerase chain reaction. J Infect Dis 1992, 166(3):507-511.
47. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. Morb Mortal Wkly Rep 2008, 57(25):697-700.
48. Hull J.J., Teel E.N., Kerin T.K., Freeman M.M., Esona M.D., Gentsch J.R., et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011, 30(1):S42-S47.
49. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375(9730):1969-1987.
50. Glass R.I. New hope for defeating rotavirus. Sci Am 2006, 294(4):46-51. 54-5.
51. Malek M.A., Curns A.T., Holman R.C., Fischer T.K., Bresee J.S., Glass R.I., et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006, 117(6):1887-1892.
52. Chen K.T., Fan S.F., Tang R.B., Huang Y.F., Lee P.I., Chen P.Y., et al. Hospital-based study of economic burden associated rotavirus diarrhea in Taiwan. Vaccine 2007, 25(21):4266-4272.
53. Wu C.L., Yang Y.C., Huang L.M., Chen K.T. Cost-effectiveness of childhood rotavirus vaccination in Taiwan. Vaccine 2009, 27:1492-1499.
54. Chen K.T., Chen P.Y., Tang R.B., Huang Y.F., Lee P.I., Chen P.Y., et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis 2005, 92. S44-8.
55. Lu C.Y., Lauderdale T.L., Fang Y.H., Wang C.Y., Ho Y.H., Hung C.L., et al. Disease Burden and related medical costs of rotavirus infections in Taiwan. BMC Infect Dis 2006, 6:176.
56. Mast T.C., Chen P.Y., Lu K.C., Hsu C.M., Lin H.C., Liao W.C., et al. Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinic in Taiwan, 2005-2006. Vaccine 2010, 28(17):3008-3013.
57. Widdowson M.A., Meltzer M.I., Zhang X., Bresee J.S., Parashar U.D., Glass R.I. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007, 119(4):684-697.
58. Standaert B., Harlin O., Desselberger U. The financial burden of rotavirus disease in four countries of the European Union. Pediatr Infect Dis J 2008, 27(1):S20-S27.
59. Rheingans R.D., Antil L., Dreibelbis R., Podewils L.J., Bresee J.S., Parashar U.D. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009, 200:S16-S27.
60. World Health Organization Generic protocols (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community based survey on utilization of health care services for gastroenteritis in children 2002, World Health Organization, Geneva.
61. Widdowson M.A., Steele D., Vojdani J., Wecker J., Parashar U. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. J Infect Dis 2009, 200:S1-S8.
62. Bresee J., Fang Z.Y., Wang B., Nelson E.A., Tam J., Soenarto Y., et al. First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis 2004, 10(6):988-995.
63. World Health Organization. Global Rotavirus Surveillance, July 23, 2010. Available from: [accessed 2.05.11]. http://www.int/nuvi/surveillance/HQBulletin_Rota_2009_final.pdf.
64. Wu F.T., Liang S.Y., Tsao K.C., Huang C.G., Lin C.Y., Lin J.S., et al. Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005-2007. Vaccine 2009, 27(5):F50-F54.
65. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005, 15(1):29-56.
66. Sharma S., Paul V.K., Bhan M.K., Ray P. Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain in Delhi, India. J Clin Microbiol 2009, 47(12):3998-4005.
67. Centers for Disease Control and Prevention (CDC) Rotavirus surveillance worldwide, 2001-2008. Morb Mortal Wkly Rep 2008, 57(46):1255-1257.
68. Iturriza-Gómara M., Dallman T., Bányai K., Böttiger B., Buesa J., Diedrich S., et al. Rotavirus surveillance in Europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data. J Infect Dis 2009, 200(1):S215-S221.
69. Wu F.T., Bányai K., Huang J.C., Wu H.S., Chang F.Y., Yang J.Y., et al. Diverse origin of P[19] rotaviruses in children with acute diarrhea in Taiwan: detection of novel lineages of the G3, G5, and G9 VP7 genes. J Med Virol 2011, 83(7):1279-1287.
70. Wu F.T., Bányai K., Huang J.C., Wu H.S., Chang F.Y., Hsiung C.A., et al. Human infection with novel G3P[25] rotavirus strain in Taiwan. Clin Microbiol Infect 2011, 17(10):1570-1573.
71. Hwang K.P., Huang Y.C., Bányai K., Wu H.S., Chang F.Y., Yang D.C., et al. Severe gastroenteritis associated with G3P[9] rotavirus in Taiwan. Infection 2011, 39(3):271-275.
72. Lin Y.P., Kao C.L., Chang S.Y., Taniguchi K., Hung P.Y., Lin H.C., et al. Determination of human rotavirus VP6 genogroups I and II by reverse transcription-PCR. J Clin Microbiol 2008, 46(10):3330-3337.
73. Chen S.Y., Chang Y.C., Lee Y.S., Chao H.C., Tsao K.C., Lin T.Y., et al. Molecular epidemiology and clinical manifestations of viral gastroenteritis in hospitalized pediatric patients in Northern Taiwan. J Clin Microbiol 2007, 45(6):2054-2057.
74. Lin Y.P., Chang S.Y., Kao C.L., Huang L.M., Chung M.Y., Yang J.Y., et al. Molecular epidemiology of G9 rotaviruses in Taiwan between 2000 and 2002. J Clin Microbiol 2006, 44(10):3686-3694.
75. Lai H.C., Lin S.J., Lin H.R., Ku C.S., Wang L., Yang C.C. Phylogenetic analyses of human rotavirus in central Taiwan in 1996, 2001 and 2002. J Clin Virol 2005, 32(3):199-217.
76. Grimwood K., Lambert S.B., Milne R.J. Rotavirus infections and vaccines: burden of illness and potential impact of vaccination. Pediatr Drugs 2010, 12(4):235-256.
77. Cunliffe N.A., Bresee J.S., Gentsch J.R., Glass R.I., Hart C.A. The expanding diversity of rotaviruses. Lancet 2002, 359(9307):640-642.
78. Bishop R.F., Barnes G.L., Cipriani E., Lund J.S. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med 1983, 309(2):72-76.
79. Kapikian A.Z., Hoshino Y., Chanock R.M., Perez-Schael I. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine. Arch Virol 1996, 12:163-175.
80. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M.A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368(9532):323-332.
81. Bresee J.S., Parashar U.D., Widdowson M.A., Gentsch J.R., Steele A.D., Glass R.I. Update on rotavirus vaccines. Pediatr Infect Dis J 2005, 24(11):947-952.
82. Perez-Schael I., Garcia D., Gonzalez M., Gonzalez R., Daoud N., Perez M., et al. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 1990, 30(3):219-229.
83. De Mol P., Zissis G., Butzler J.P., Mutwewingabo A., André F.E. Failure of live, attenuated oral rotavirus vaccine. Lancet 1986, 2(8498):108.
84. Santosham M., Letson G.W., Wolff M., Reid R., Gahagan S., Adams R., et al. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 1991, 163(3):483-487.
85. Vesikari T., Isolauri E., D'Hondt E., Delem A., André F.E., Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984, 1(8384):977-981.
86. Fu C., Wang M., Liang J., He T., Wang D., Xu J. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine 2007, 25(52):8756-8761.
87. Wang H., Duan Z.J. Research and application advances in live oral rotavirus vaccines. Chinese J Virol 2009, 25:238-242.
88. Midthun K., Kapikian A.Z. Rotavirus vaccines: an overview. Clin Microbiol Rev 1996, 9(3):423-434.
89. Joensuu J., Koskenniemi E., Pang X.L., Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997, 350(9086):1205-1209.
90. Centers for Disease Control and Prevention Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999, 48(RR-2):1-20.
91. Centers for Disease Control and Prevention (CDC) Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. Morb Mortal Wkly Rep 1999, 48(27):577-581.
92. Simosen L., Viboud C., Elixhauser A., Taylor R.J., Kapikian A.Z. More on RotaShield and intussusceptions: the role of age at the time of vaccination. J Infect Dis 2005, 192(1):S36-S43.
93. Patel M.M., López-Collada V.R., Bulhões M.M., De Oliveira L.H., Bautista Márquez A., Flannery B., et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011, 364:2283-2292.
94. Clark H.F., Offit P.A., Ellis R.W., Eiden J.J., Krah D., Shaw A.R., et al. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis 1996, 174(1):S73-S80.
95. Clark H.F., Bernstein D.I., Dennehy P.H., Offit P., Pichichero M., Treanor J., et al. Safety, efficacy and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004, 144(2):184-190.
96. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33.
97. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007 Nov 24, 370(9601):1757-1763.
98. Rennels M.B., Glass R.I., Dennehy P.H., Bernstein D.I., Pichichero M.E., Zito E.T., et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 1996, 97:7-13.
99. Ruiz-Palacios G.M., Pérez-Schael I., Velázquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354:11-22.
100. Phua K.B., Lim F.S., Lau Y.L., Nelson E.A., Huang L.M., Quak S.H., et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomized, double-blind, controlled study. Vaccine 2009, 27(43):5936-5941.
101. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomized, double-blind, placebo-controlled trial. Lancet 2010, 376:606-614.
102. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
103. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362:289-298.
104. EL Khoury A., Mast T.C., Ciarlet M., Markson L.E., Goveia M.G. Projecting the effectiveness of RotaTeq against rotavirus-related hospitalizations and deaths in six Asian countries. Hum Vaccine 2011, 7(5):506-510.
105. Plusher G.L. Pentavalent rotavirus vaccine (RotaTeg): a review of its use in the prevention of rotavirus gastroenteritis in Europe. Drugs 2010, 70(9):1165-1188.
106. Vesikari T., Itzler R., Karvonen A., Korhonen T., Van Damme P., Behre U., et al. RotaTeg, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. Vaccine 2009, 28(2):345-351.
107. Christie C.D., Duncan N.D., Thame K.A., Onorato M.T., Smith H.D., Malcolm L.G., et al. Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization. Pediatrics 2010, 126(6):1499-1506.
108. Parashar U.D., Alexander J.P., Glass R.I. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-12):1-13.
109. Haber P., Patel M., Izurieta H.S., Baggs J., Gargiullo P., Weintraub E., et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008, 121(6):1206-1212.
110. Clements-Mann M.L., Makhene M.K., Mrukowicz J., Wright P.F., Hoshino Y., Midthun K., et al. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine 1999, 17(20-21):2715-2725.
111. Bernstein D.I., Sack D.A., Rothstein E., Reisinger K., Smith V.E., O'Sullivan D., et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomized placebo-controlled trail. Lancet 1999, 354(9175):287-290.
112. Bernstein D.I., Sack D.A., Reisinger K., Rothstein E., Ward R.L. Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants. J Infect Dis 2002, 186(10):1487-1489.
113. De Vos B., Vesikari T., Linhares A.C., Salinas B., Pérez-Schael I., Ruiz-Palacios G.M., et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatri Infect Dis J 2004, 23(10):S179-S182.
114. Linhares A.C., Velázquez F.R., Pérez-Schael I., Sáez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomized, double-blind, placebo-controlled phase III study. Lancet 2008, 371(9619):1181-1189.
115. Barnes G.L., Lund J.S., Adams L., Mora A., Mitchell S.V., Caples A., et al. Phase I trial of a candidate rotavirus vaccine (RV3) derived from a human neonate. J Paediatr Child Health 1997, 33(4):300-304.
116. Das B.K., Gentsch J.R., Hoshino Y., Ishida S., Nakagomi O., Bhan M.K., et al. Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E. Virology 1993, 197(1):99-107.
117. Das M., Dunn S.J., Woode G.N., Greenberg H.B., Rao C.D. Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology 1993, 194(1):374-379.
118. Iturriza Gómara M., Kang G., Mammen A., Jana A.K., Abraham M., Desselberger U., et al. Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol 2004, 42(6):2541-2547.
119. Offit P.A., Hoffenberg E.J., Santos N., Gouvea V. Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J Infect Dis 1993, 167(6):1436-1440.
120. Velázquez F.R., Matson D.O., Calva J.J., Guerrero L., Morrow A.L., Carter-Campbell S., et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996, 335(14):1022-1028.
121. Chiba S., Yokoyama T., Nakata S., Morita Y., Urasawa T., Taniguchi K., et al. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1986, 2(8504):417-421.
122. Jiang B., Gentsch J.R., Glass R.I. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis 2002, 34(10):1351-1361.
123. Yang K., Wang S., Chang K.O., Lu S., Saif L.J., Greenberg H.B., et al. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection. Vaccine 2001, 19(23-24):3285-3291.
124. Wang Y., Azevedo M., Saif L., Gentsch J.R., Glass R.I., Jiang B. Inactivated rotavirus vaccine induce protective immunity in gnotobiotic piglets. Vaccine 2010, 28:5432-5436.
125. Crawford S.E., Estes M.K., Ciarlet M., Barone C., O'Neal C.M., Cohen J., et al. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J Virol 1999, 73(6):4813-4822.